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Reoperative innominate arterial, ascending aortic, and root replacement
for extensive fungal endocarditis
Bradley G. Leshnower, MD, and Thomas G. Gleason, MD, Philadelphia, Pa
Fungal endocarditis is a rare but lethal disease with amortality rate exceeding 50%.1,2 The diagnosis is fre-quently elusive because the results of blood cultures arenegative in 50% of cases.1,2 It is characterized by bulky
and exophytic vegetations that typically emobolize.1 Prominent
risk factors include anatomic cardiac abnormalities, previous valve
operations, indwelling venous catheters, and the use of broad-
spectrum antibiotics.1,2 We report an unusual case of extensive
Candida non-albicans endocarditis involving a mechanical valved
conduit, ascending aortic graft, and innominate arterial graft 8
months after a complicated type A aortic dissection repair.
Clinical Summary
A 45-year-old man underwent a complicated repair of an acute
type A aortic dissection, including a mechanical valved root and
ascending aortic and innominate arterial replacement, at another
institution. Eight months later, the patient presented with a tem-
perature of 103°F and right ankle cellulitis surrounding a spider
bite. Blood cultures grew Candida dubliniensis. Transesophageal
echocardiography (TEE) demonstrated a small vegetation above
the left coronary os. The patient was started on a regimen of
caspofungin and transferred to our institution.
Repeat TEE confirmed the presence of the vegetation. The
results of repeat blood cultures were negative. The patient was now
afebrile and had no clinical signs or symptoms of endocarditis. He
was discharged home receiving intravenous caspofungin therapy.
At his follow-up examination 4 weeks later, the patient remained
afebrile and asymptomatic, and the results of blood cultures were still
negative. Repeat TEE and computed tomographic angiography
(CTA) demonstrated an interval increase in the number and size of the
vegetations (Figures 1 and 2, A). He was started on a regimen of
amphotericin B and underwent surgical exploration.
Opening of the ascending aortic graft revealed extensive and
exophytic vegetations within the aortic root and ascending aortic
and innominate arterial prosthetic grafts, with far more fungal
burden seen than was predicted by either the TEE or CTA. All
gross infection was confined to within the prosthetic grafts, with no
invasion of the periannular structures. Immediate Gram staining
revealed abundant budding yeast identified as Candida parapsilo-
sis. All prosthetic graft, pledget material, and previously placed
BioGlue (CryoLife, Inc, Kennesaw, Ga) were removed, and the
arch was reconstructed during hypothermic circulatory arrest. The
aortic graft, arch, and innominate arterial grafts were replaced with
28-mm and 12-mm polyester grafts. A 23-mm Medtronic Freestyle
porcine bioprosthesis (Medtronic, Inc, Minneapolis, Minn) was
used to replace the aortic root after complete debridement.
The patient had an uneventful hospital course receiving intra-
venous amphotericin B and oral 5-flucytosine and was discharged
on day 12 with a prescription for these drugs. After 4 months, the
antifungal regimen was changed to daily oral fluconazole for
long-term suppression. After more than 12 months of follow-up,
there have been no signs or symptoms of endocarditis. Follow-up
TEE and CTA at 3, 6, and 12 months demonstrated no evidence of
recurrent endocarditis (Figure 2, B).
Discussion
Fungi are responsible for 1.3% to 6% of all cases of infective endo-
carditis.1,2 Most cases are caused by Candida albicans, but Candida
parapsilosis is a more commonly isolated non-albicans species. Fun-
gal pathogens create a biofilm, which aids in adherence to endothelial
or prosthetic surfaces and prevents antifungal penetration, enabling
persistent and recurrent infection.3 The high mortality rate of patients
with fungal endocarditis correlates with a recurrence rate of 30%. 1,2
An attempt at medical therapy is justified in patients with asymp-
tomatic disease, particularly in the setting of reoperative cardiac
surgery.4 However, medically treated patients require close follow-up,
regardless of symptomatology. In this case surveillance TEE demon-
strated an interval increase in the size and number of vegetations after
4 weeks of intravenous antifungal therapy, but neither TEE nor CTA
depicted the true fungal burden, which extended throughout the pros-
thetic graft material.
A porcine bioprosthetic root was a good option for this case
because the fungal burden was not invading the heart or the native
vessels, the annulus was small given the patient’s size, and the
bioprosthetic root offered a better valvular hemodynamic profile than
a mechanical valve of equal size. Although, historically, homograft
replacement has been touted as the optimal strategy for reoperative
endocarditis, neither late survival nor reoperation-free survival has
been shown to be reduced by homograft use compared with use of
other biologic or mechanical valves.5 Recurrences have been attrib-
uted to the discontinuation of long-term antifungal suppressive ther-
apy and not to valve choice.6 Freestyle bioroots now appear to offer
better 8-year freedom from structural deterioration and aortic insuffi-
ciency than homografts,7,8 and they might be a better long-term
option when invasive infection is not present.
We conclude from this case that failed medical therapy, as
demonstrated by TEE indicating a progression of the size, number,
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or both of endocardial vegetations, can be a marker for more
extensive endocardial fungal burden than is clinically apparent.
This finding should prompt an aggressive multimodal strategy,
including perioperative intravenous antifungal therapy, radical ex-
cision of infected prostheses and tissues, valve replacement, and
long-term suppressive antifungal therapy. The patient described in
this report continues to receive fluconazole and undergoes hepatic
transaminase surveillance bimonthly and both TEE and CTA sur-
veillance every 6 months.
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Figure 1. Preoperative TEE images of the aortic root in the long axis (A) and short axis (B) demonstrate
endovascular fungal vegetations (arrows). The left atrium (LA) and aorta (AO) are labeled.
Figure 2. A, Preoperative multidetector helical CTA of the chest demonstrates endovascular vegetation near the
left coronary os (veg). There is a small endovascular mass within the descending thoracic aorta that might
represent either thrombus or vegetation (clot/veg?). Residual dissection is noted in the descending thoracic aorta.
B, CTA 12 months postoperatively demonstrated no vegetation in the aorta or innominate arteries and complete
resolution of the endovascular thrombus-vegetation in the descending thoracic artery. The porcine bioroot valve
cusps are well visualized. The maximum diameter of the descending thoracic artery was noted to increase from
38 mm to 40 mm over the 12-month period.
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